Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
22/09/2025
After Latam Airlines ordered the E195-E2 aircraft, the stock price of Brazilian aerospace company rose by 3.4%.
Latest
3 m ago
The price of Apple stock rose by 4.1% at one point.
4 m ago
Kitchen consumables (aluminum foil, plastic wrap, garbage bags, etc.) brand manufacturer Reynold Consumer Products (REYN) rose 4% in early trading after being selected to join the S&P SmallCap 600 index. The inclusion, effective on September 24th, reflects Reynold's strong market performance.
4 m ago
Reynolds Consumer Products, a kitchen consumer goods brand manufacturer, saw a 4% increase in early trading, after being added to the S&P SmallCap 600 index. The inclusion will be effective on September 24th, reflecting Reynolds' strong market performance.
6 m ago
Roche pharmaceutical company reported positive results from a late-stage trial of its breast cancer drug combination. The trial met its primary endpoint, showing a significant improvement in progression-free survival, pushing Roche's stock price up by 1.5%.
6 m ago
Roche Pharmaceuticals (RHHBY) reported positive results from a late-stage trial of its breast cancer drug combination, including its new breast cancer drug, giredestrant. The trial met its primary endpoint showing a significant improvement in progression-free survival, leading to a 1.5% increase in Roche's stock price.
See all latest